In line with this evidence, treatment with anti-IL-25 blocking antibody significantly reduced IL-4-producing CD4+ Th2 cells in the MMTV-PyMT breast tumor model (Fig. 4A). The gene discussed is IL25; the disease is breast neoplasm.